Harlan M. Krumholz, MD

home / authors / harlan-m-krumholz-md

Articles

July 1st 2001

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

S. Nicole Fehrenbach, MPP Daniel S. Budnitz, MD, MPH Julie A. Gazmararian, MPH, PhD Harlan M. Krumholz, MD

June 1st 1999

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction

Harlan M. Krumholz, MD Ya-ting Chen, PhD W. David Bradford, PhD Julie Cerese, RN, MSN

December 1st 1998

Trends in Costs of Percutaneous Transluminal Coronary Angioplasty

Asefeh Heiat, MD Jennifer A. Mattera, MPH Glen A. Henry, MD Ya-ting Chen, PhD Harlan M. Krumholz, MD

April 1st 1997

Differences in Physician Compensation for Cardiovascular Services by Age, Sex, and Race

Harlan M. Krumholz, MD A. Mark Fendrick, MD Christianna Williams, MA William M. Hynes

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions